<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Turk J Haematol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Turk J Haematol</journal-id>
      <journal-id journal-id-type="publisher-id">TJH</journal-id>
      <journal-title-group>
        <journal-title>Turkish Journal of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1300-7777</issn>
      <issn pub-type="epub">1308-5263</issn>
      <publisher>
        <publisher-name>Galenos Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27020724</article-id>
      <article-id pub-id-type="pmc">4805345</article-id>
      <article-id pub-id-type="doi">10.4274/tjh.2015.0169</article-id>
      <article-id pub-id-type="publisher-id">1602</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Extranodal Natural Killer/T-Cell Lymphoma: A Rare Nasal-Type Case</article-title>
        <trans-title-group xml:lang="tr">
          <trans-title>Ekstranodal Natural Killer/T-H&#xFC;creli Lenfoma: Nadir Bir Nasal Tip Olgusu</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sar&#x131;bacak Can</surname>
            <given-names>Esra</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okutan</surname>
            <given-names>Harika</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Albayrak</surname>
            <given-names>Murat</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Han</surname>
            <given-names>&#xDC;nsal</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>
D&#x131;&#x15F;kap&#x131; Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t Research and Training Hospital, Clinic of Hematology, Ankara, Turkey
</aff>
      <aff id="A2"><label>2</label>
D&#x131;&#x15F;kap&#x131; Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t Research and Training Hospital, Clinic of Pathology, Ankara, Turkey
</aff>
      <author-notes>
        <corresp id="COR1">* Address for Correspondence: D&#x131;&#x15F;kap&#x131; Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t Research and Training Hospital, Clinic of Hematology, Ankara, Turkey E-mail: <email>esracanercan@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>2</month>
        <year>2016</year>
      </pub-date>
      <volume>33</volume>
      <issue>1</issue>
      <fpage>74</fpage>
      <lpage>75</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>9</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Turkish Journal of Hematology, Published by Galenos Publishing.&#xD;
</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Extranodal natural killer/T-cell lymphoma</kwd>
        <kwd>non-Hodgkin lymphoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>TO THE EDITOR</title>
      <p>Nasal type extranodal natural killer (NK) NK-cell/T-cell lymphoma (NKTCL) is a rare extranodal lymphoma of NK-cell or T-cell origin that most commonly affects immunocompetent middle-aged men of Asian or Native American descent [<xref rid="ref1" ref-type="bibr">1</xref>]. The pathogenesis is not understood completely, but it is related in part to infection of the tumor cells with Epstein-Barr virus (EBV) [<xref rid="ref2" ref-type="bibr">2</xref>]. Around 6-7% of all non-Hodgkin&#x2019;s lymphoma (NHL) in Southeast Asia accounts for NKTCL. However, the incidence of NHL is lower in the United States at 1.5% [<xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref4" ref-type="bibr">4</xref>].</p>
      <p>Disease within the nasal cavity has a better prognosis. Radiation therapy alone can be curative. Over 60% of patients with stage 1 disease remain in long-term remission following treatment with radiation therapy with or without chemotherapy [<xref rid="ref5" ref-type="bibr">5</xref>]. Nasal disease may be cured with radiotherapy at a rate of 85%. However, the relapse rate is high at 25%. Therefore, it is highly crucial for this aggressive disease to be diagnosed and treated at an early stage [<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref7" ref-type="bibr">7</xref>].</p>
      <p>In our case, a 29-year-old female complained of nasal obstruction and had a necrotizing mass in the upper middle concha at the right nasal cavity; biopsy was planned. CD56 was strongly positive (<xref ref-type="fig" rid="f1">Figure 1</xref>), CD8 was positive in a few scattered cells, and CD4 was positive in the majority of infiltrating T cells in the sample of necrotic tissue pieces. TIA-1 and perforin were commonly positive. Granzyme was commonly strongly cytoplasmic-positive. Epstein-Barr encoding region (EBER) in situ hybridization analysis was done with a probe cocktail containing EBV. Early RNA transcript showed that NKTCL compatibility existed with commonly strongly nuclear-positivity in EBER infiltrating cells. Positron emission tomography-computed tomography (PET-CT) revealed pathologically heterogeneous soft tissue mucosal thickening, pushing the nasal septum slightly to the left and hypertrophy of the right ethmoid cells in the upper middle concha level of the nasal cavity, with increased metabolic uptake (SUVmax: 3.18). The patient was diagnosed with stage 1E based on PET-CT evaluation and received a total of 38 Gy external radiotherapy at 200 cGy daily. No involvement was detected month after radiotherapy and complete response was considered to have occurred after 1 year.</p>
      <p>NKTCL of the palate and sinuses has been reported in many cases. However, the incidence of NKTCL is much lower in the United States. Nasal obstruction, bleeding, pain, or local swelling are usually observed and ulcerative, destructive lesions within extranodal sites can be produced. Often it is associated with EBV. Immunophenotypically, the tumor cells express CD2, CD3, and CD56. The cells can lack CD56 and express CD8+ T-cell antigens in some cases [<xref rid="ref7" ref-type="bibr">7</xref>]. The course of NKTCL, nasal type, is aggressive where a 5-year overall survival ranges from 25% to 50% [<xref rid="ref8" ref-type="bibr">8</xref>].</p>
      <p>Symptoms of nasal type NKTCL can include nasal discharge, nasal obstruction and other nonspecific sinonasal symptoms. However, sore throat and dysphagia, also known as symptoms of nasal type NKTCL, are frequently missed and treated as viral and bacterial pharyngitis, which leads to late diagnosis. Therefore, morbidity and mortality are increased. NK/T-cell lymphoma, nasal type, is rarely observed in Turkey and early diagnosis of the disease is of vital importance.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="FN3" fn-type="con">
        <p>Concept: Esra Sar&#x131;bacak Can, Design: Esra Sar&#x131;bacak Can, Data Collection or Processing: Esra Sar&#x131;bacak Can, Analysis or Interpretation: Esra Sar&#x131;bacak Can, Harika Okutan, Literature Search: Esra Sar&#x131;bacak Can, Murat Albayrak, Writing: Esra Sar&#x131;bacak Can, &#xDC;nsal Han.</p>
      </fn>
      <fn id="FN1" fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Roschewski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>EBV-associated lymphomas in adults</article-title>
          <source>Best Pract Res Clin Haematol</source>
          <year>2012</year>
          <volume>25</volume>
          <fpage>75</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="pmid">22409825</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Niedobitek</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma</article-title>
          <source>Mol Pathol</source>
          <year>2000</year>
          <volume>53</volume>
          <fpage>248</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="pmid">11091848</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Hakeem</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Fedele</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Carlos</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Extranodal NK/T-cell lymphoma, nasal type</article-title>
          <source>Oral Oncol</source>
          <year>2007</year>
          <volume>43</volume>
          <fpage>4</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">17064952</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Jaccard</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hermine</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Extranodal natural killer/T-cell lymphoma: advances in the management</article-title>
          <source>Curr Opin Oncol</source>
          <year>2011</year>
          <volume>23</volume>
          <fpage>429</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="pmid">21743325</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>QF</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>YP</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>LQ</given-names>
            </name>
            <name>
              <surname>Ouyang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>YX</given-names>
            </name>
          </person-group>
          <article-title>Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2014</year>
          <volume>88</volume>
          <fpage>806</fpage>
          <lpage>813</lpage>
          <pub-id pub-id-type="pmid">24495590</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Liang</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and management of primary nasal lymphoma of T-cell or NK-cell origin</article-title>
          <source>Clin Lymphoma</source>
          <year>2000</year>
          <volume>1</volume>
          <fpage>33</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="pmid">11707809</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Hasserjian</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title>NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype</article-title>
          <source>Am J Clin Pathol</source>
          <year>2007</year>
          <volume>127</volume>
          <fpage>860</fpage>
          <lpage>868</lpage>
          <pub-id pub-id-type="pmid">17509983</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Kwong</surname>
              <given-names>YL</given-names>
            </name>
          </person-group>
          <article-title>Natural killer-cell malignancies: diagnosis and treatment</article-title>
          <source>Leukemia</source>
          <year>2005</year>
          <volume>19</volume>
          <fpage>2186</fpage>
          <lpage>2194</lpage>
          <pub-id pub-id-type="pmid">16179910</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title>Strong staining of diffuse cytoplasmic natural killer cells with CD56 (CD56, IHC, 200x).</title>
      </caption>
      <graphic xlink:href="TJH-33-74-g1"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
